Top Markets
Coin of the day
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
Clasificación en acciones #34084
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
Precio por acción
$0.02082992
Última sincronización: 2026-08-14
Capitalización bursátil
$6.27M
Cambio (1 día)
-3.31%
Cambio (1 año)
-51.62%
País
RU
Comercio PJSC Pharmsynthez (LIFE)

Categoría

Historial del precio de la acción de PJSC Pharmsynthez (LIFE)
Precio más alto de cierre: $0.02 el 2026-08-01

Precio más bajo de cierre: $0.76 el 2010-11-01
Historial del precio de la acción de PJSC Pharmsynthez desde 2010 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -9.44%
2025 30.97%
2024 -44.82%
2023 -11.95%
2022 -18.74%
2021 -19.66%
2020 45.23%
2019 -22.41%
2018 -56.43%
2017 -26.82%
2016 72.01%
2015 -33.83%
2014 -51.22%
2013 7.71%
2012 -30.67%
2011 -14.49%
2010 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE